Jack Kaye, a director at $QURE, sold 2,645 shares of the company on 06-03-2026 for an estimated $79,376. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.5% of their shares of this class of stock. Following this trade, they now own 20,439 shares of this class of $QURE stock.
$QURE Insider Trading Activity
$QURE insiders have traded $QURE stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $QURE stock by insiders over the last 6 months:
- MATTHEW C KAPUSTA (CEO, Managing Director) has made 0 purchases and 3 sales selling 61,396 shares for an estimated $770,091.
- ROBERT GUT has made 0 purchases and 3 sales selling 25,613 shares for an estimated $630,483.
- CHRISTIAN KLEMT (Chief Financial Officer) has made 0 purchases and 3 sales selling 30,749 shares for an estimated $381,751.
- JACK KAYE has made 0 purchases and 2 sales selling 9,035 shares for an estimated $253,695.
- JEANNETTE POTTS (Chief Legal Officer) has made 0 purchases and 2 sales selling 11,990 shares for an estimated $116,263.
- WALID ABI-SAAB (Chief Medical Officer) has made 0 purchases and 2 sales selling 2,468 shares for an estimated $23,837.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$QURE Hedge Fund Activity
We have seen 115 institutional investors add shares of $QURE stock to their portfolio, and 167 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 4,497,128 shares (-72.1%) from their portfolio in Q1 2026, for an estimated $73,528,042
- ECOR1 CAPITAL, LLC removed 3,988,971 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $95,456,076
- JPMORGAN CHASE & CO added 1,785,275 shares (+155.3%) to their portfolio in Q4 2025, for an estimated $42,721,630
- ABERDEEN GROUP PLC added 1,627,746 shares (+44.2%) to their portfolio in Q1 2026, for an estimated $26,613,647
- ORBIMED ADVISORS LLC added 1,398,749 shares (+189.7%) to their portfolio in Q1 2026, for an estimated $22,869,546
- TWO SEAS CAPITAL LP added 1,300,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $21,255,000
- TWO SIGMA INVESTMENTS, LP added 1,224,587 shares (+84.4%) to their portfolio in Q1 2026, for an estimated $20,021,997
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$QURE Analyst Ratings
Wall Street analysts have issued reports on $QURE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 12/11/2025
- Mizuho issued a "Outperform" rating on 12/09/2025
To track analyst ratings and price targets for $QURE, check out Quiver Quantitative's $QURE forecast page.
$QURE Price Targets
Multiple analysts have issued price targets for $QURE recently. We have seen 9 analysts offer price targets for $QURE in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $50.0 on 05/06/2026
- Daniil Gataulin from Chardan Capital set a target price of $37.0 on 04/30/2026
- Salveen Richter from Goldman Sachs set a target price of $10.0 on 04/20/2026
- Eliana Merle from Barclays set a target price of $25.0 on 03/23/2026
- Uy Ear from Mizuho set a target price of $35.0 on 03/11/2026
- Luca Issi from RBC Capital set a target price of $35.0 on 03/09/2026
- Yanan Zhu from Wells Fargo set a target price of $60.0 on 03/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
